跳至主要内容
临床试验/NCT06389630
NCT06389630Unknown不适用

Evaluation of the Efficiency of Two Different Teaching Methods in Safe Subcutaneous Injection Skills in Type 2 Diabetes Mellitus Patients

Kocaeli Sağlık ve Teknoloji Üniversitesi0 个研究点目标入组 82 人开始时间: 2024年4月29日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
82
主要终点
subcutaneous injection skills

研究概览

简要总结

Subject: Subcutaneous (SC) insulin injection is frequently used in the treatment of Type 2 Diabetes patients. Complications such as pain, ecchymosis, hematoma, lipoatrophy and lipohypertrophy are frequently observed after SC injections. These complications that develop due to incorrect injection application negatively affect the use of injection application areas, change body image and negatively affect drug absorption. In order to reduce and prevent complications related to SC insulin injection, it is very important to gain the skill of safe SC insulin injection. It is stated that there are a limited number of studies on which of the teaching methods used in sick individuals are effective. In the national and international literature, no study has been found evaluating the effect of SC injection skill teaching based on video-supported training and low-fidelity simulation model applications on disease management in individuals diagnosed with Type 2 Diabetes Mellitus. In this regard, the research was planned as an experimental design in order to examine the effectiveness of video-supported training and low-fidelity simulation model-based teaching in gaining safe insulin injection skills via SC. For this purpose; It is aimed to evaluate the effect of two different skill teaching methods on the patient's SC injection ability, complication management and blood glucose level.

Purpose: This research was planned as an experimental design to examine the effectiveness of two different teaching methods (video-supported training and low-fidelity simulation model) in gaining safe insulin injection skills via the Subcutaneous (SC) route.

Design: A pretest-posttest two-group, quasi-experimental design will be used in the study.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The patient must be 18 years of age or older,
  • Have the physical and mental ability to accurately evaluate the Visual Analog Scale (VAS),
  • The platelet count is 100 000/mm3 and above,
  • Having a diagnosis of Type 2 Diabetes Mellitus,
  • No dementia according to Mini-Cog test evaluation,
  • The plan was to agree to participate in the study.

排除标准

  • Having verbal and auditory problems,
  • Using oral or SC anticoagulant
  • Presence of any findings such as scarring, incision, ecchymosis, hematoma, lipoarthrrophy and lipohypertrophy on the skin in the area where the injection will be made,
  • Recurrent use of drugs that affect the formation of lipoatrophy and lipohypertrophy, such as octroid, corticosteroid, and antiretroviral therapy,
  • It was defined as having a diagnosis of Diabetes during pregnancy.

结局指标

主要结局

subcutaneous injection skills

时间窗: After 1 week, After 1 month, After 3 months

The "subcutaneous injection checklist" will be used to measure patients' ability to administer subcutaneous injection.

hematoma

时间窗: After 1 week, After 1 month, After 3 months

Opsite-Flexigrid Measurement Tool" will be used to measure hematoma that occur after subcutaneous injection.

pain

时间窗: during the first week, 1st month and the last week before the 3rd month

Pain occurring after subcutaneous injection will be measured with "visual analog scale". These values will be written into the chart.

ecchymosis

时间窗: After 1 week, After 1 month, After 3 months

"Opsite-Flexigrid Measurement Tool" will be used to measure ecchymosis that occur after subcutaneous injection.

lipoarthrrophy

时间窗: After 1 week, After 1 month, After 3 months

Lipoatrrophy occurring after subcutaneous insulin injection will be determined by inspection and palpation.

lipohypertrophy

时间窗: After 1 week, After 1 month, After 3 months

lipohypertrophy occurring after subcutaneous insulin injection will be determined by inspection and palpation.

blood glucose level

时间窗: during the first week, 1st month and the last week before the 3rd month

Blood glucose values will be measured by patients with a blood glucose meter. These values will be written into the chart.

次要结局

未报告次要终点

研究者

发起方
Kocaeli Sağlık ve Teknoloji Üniversitesi
申办方类型
Other
责任方
Principal Investigator
主要研究者

Azzet Yüksel

Lecturer,Principal Investigator

Kocaeli Sağlık ve Teknoloji Üniversitesi

相似试验